会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • LIPOSOMAL SYSTEMS COMPRISING SPHINGOMYELIN
    • 包含SPHINGOMYELIN的脂质体系
    • WO2010041255A2
    • 2010-04-15
    • PCT/IL2009/000966
    • 2009-10-11
    • YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD.BARENHOLZ, YechezkelCOHEN, Rivka
    • BARENHOLZ, YechezkelCOHEN, Rivka
    • A61K9/127A61K31/445
    • A61K9/127A61K31/445A61K31/573
    • The present disclosure provides a liposomal system comprising an aqueous medium having dispersed therein liposomes encapsulating in their intraliposomal aqueous compartment at least one active agent, the aqueous medium being in iso-osmotic equilibrium with said intraliposomal aqueous compartment, the liposomes having a membrane comprising a liposome forming lipids, at least one of which being sphingomyelin (SPM), the liposomal system having increased stability as compared to the same liposomes free of SPM, and in one embodiment being stable during long-term storage, said stability being characterized in that no more than 30% of the at least one active agent is present in the aqueous medium after said storage. Further provided by the present disclosure are a method for storage of liposomes making use of the liposomal system; use of the liposomal system for the treatment of a medical condition or for the diagnostic of a medical condition; a pharmaceutical or diagnostic composition comprising the liposomal system, and a method of treating or diagnosing of a medical condition comprising administering to a subject an amount of the liposomal system.
    • 本公开提供了一种脂质体系统,其包含水分介质,其中分散有脂质体,其脂质体包封在其脂质体内水性隔室中至少一种活性剂,所述水性介质与所述脂质体内水性隔室处于等渗平衡,所述脂质体具有包含脂质体的膜 形成脂质,其中至少一种是鞘磷脂(SPM),与没有SPM的相同脂质体相比,脂质体系统具有增加的稳定性,并且在一个实施方案中在长期储存期间是稳定的,所述稳定性的特征在于不再有 在所述储存之后,至少一种活性剂的30%以上存在于水性介质中。 本公开进一步提供的是利用脂质体系统储存脂质体的方法; 使用脂质体系统治疗医疗状况或诊断医疗状况; 包含脂质体系统的药物或诊断组合物,以及治疗或诊断医学病症的方法,其包括向受试者施用一定量的脂质体系统。
    • 9. 发明申请
    • LIPOSOMAL SYSTEMS COMPRISING SPHINGOMYELIN
    • 包含SPHINGOMYELIN的脂质体系
    • WO2010041255A3
    • 2011-04-07
    • PCT/IL2009000966
    • 2009-10-11
    • YISSUM RES DEV COBARENHOLZ YECHEZKELCOHEN RIVKA
    • BARENHOLZ YECHEZKELCOHEN RIVKA
    • A61K9/127A61K31/445
    • A61K9/127A61K31/445A61K31/573
    • The present disclosure provides a liposomal system comprising an aqueous medium having dispersed therein liposomes encapsulating in their intraliposomal aqueous compartment at least one active agent, the aqueous medium being in iso-osmotic equilibrium with said intraliposomal aqueous compartment, the liposomes having a membrane comprising a liposome forming lipids, at least one of which being sphingomyelin (SPM), the liposomal system having increased stability as compared to the same liposomes free of SPM, and in one embodiment being stable during long-term storage, said stability being characterized in that no more than 30% of the at least one active agent is present in the aqueous medium after said storage. Further provided by the present disclosure are a method for storage of liposomes making use of the liposomal system; use of the liposomal system for the treatment of a medical condition or for the diagnostic of a medical condition; a pharmaceutical or diagnostic composition comprising the liposomal system, and a method of treating or diagnosing of a medical condition comprising administering to a subject an amount of the liposomal system.
    • 本公开提供了一种脂质体系统,其包含水分介质,其中分散有脂质体,其脂质体包封在其脂质体内水性隔室中至少一种活性剂,所述水性介质与所述脂质体内水性隔室处于等渗平衡,所述脂质体具有包含脂质体的膜 形成脂质,其中至少一种是鞘磷脂(SPM),与没有SPM的相同脂质体相比,脂质体系统具有增加的稳定性,并且在一个实施方案中在长期储存期间是稳定的,所述稳定性的特征在于不再有 在所述储存之后,至少一种活性剂的30%以上存在于水性介质中。 本公开进一步提供的是利用脂质体系统储存脂质体的方法; 使用脂质体系统治疗医疗状况或诊断医疗状况; 包含脂质体系统的药物或诊断组合物,以及治疗或诊断医学病症的方法,其包括向受试者施用一定量的脂质体系统。